id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2463364,fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea,Q2,AMERICAN PHARMACISTS ASSOCIATION,3071,AMERICAN PHARMACISTS ASSOCIATION,2020,second_quarter,HCR,"H.R. 2482/S. 2074 Mainstreaming Addiction Treatment Act of 2019-
To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment, and for other purposes.
H.R. 6800 - This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.","HOUSE OF REPRESENTATIVES,SENATE",,34000,0,0,2020-07-10T12:21:58.880000-04:00